Armistice Capital’s NLS Pharmaceutics Ltd. Warrant NLSPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250 | Hold |
12,500
| – | – | ﹤0.01% | 200 |
|
|
2025
Q1 | $161 | Hold |
12,500
| – | – | ﹤0.01% | 220 |
|
|
2024
Q4 | $163 | Hold |
12,500
| – | – | ﹤0.01% | 220 |
|
|
2024
Q3 | $143 | Sell |
12,500
-487,500
| -98% | -$5.58K | ﹤0.01% | 254 |
|
|
2024
Q2 | $17.3K | Hold |
500,000
| – | – | ﹤0.01% | 237 |
|
|
2024
Q1 | $24.5K | Hold |
500,000
| – | – | ﹤0.01% | 314 |
|
|
2023
Q4 | $28.1K | Hold |
500,000
| – | – | ﹤0.01% | 264 |
|
|
2023
Q3 | $52.6K | Hold |
500,000
| – | – | ﹤0.01% | 223 |
|
|
2023
Q2 | $53.5K | Sell |
500,000
-1
| -0% | – | ﹤0.01% | 198 |
|
|
2023
Q1 | $75K | Buy |
500,001
+1
| +0% | – | ﹤0.01% | 195 |
|
|
2022
Q4 | $145K | Hold |
500,000
| – | – | ﹤0.01% | 156 |
|
|
2022
Q3 | $125K | Hold |
500,000
| – | – | ﹤0.01% | 172 |
|
|
2022
Q2 | $60 | Hold |
500,000
| – | – | ﹤0.01% | 172 |
|
|
2022
Q1 | $190K | Hold |
500,000
| – | – | ﹤0.01% | 126 |
|
|
2021
Q4 | $250K | Hold |
500,000
| – | – | ﹤0.01% | 140 |
|
|
2021
Q3 | $413K | Hold |
500,000
| – | – | 0.01% | 129 |
|
|
2021
Q2 | $452K | Hold |
500,000
| – | – | 0.01% | 112 |
|
|
2021
Q1 | $475K | Buy |
+500,000
| New | +$475K | 0.01% | 104 |
|